Potential markers for sample size estimations in hereditary spastic paraplegia type 5

BACKGROUND: Aim to identify potential biomarkers to assess therapeutic efficacy for hereditary spastic paraplegias type 5 (SPG5) by investigating the clinical, cerebrospinal fluid (CSF) and magnetic resonance imaging (MRI) features. METHODS: We performed a cross-sectional study to compare SPG5 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Qianqian, Liu, Ying, Ye, Zhixian, Hu, Jianping, Cai, Wenjie, Weng, Qiang, Chen, Wan-Jin, Wang, Ning, Cao, Dairong, Lin, Yi, Fu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451094/
https://www.ncbi.nlm.nih.gov/pubmed/34538260
http://dx.doi.org/10.1186/s13023-021-02014-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451094/
https://www.ncbi.nlm.nih.gov/pubmed/34538260
http://dx.doi.org/10.1186/s13023-021-02014-w

Ejemplares similares